Related Experiment Video
Updated: May 29, 2026
03:55
Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
Approach to the patient with advanced differentiated thyroid cancer
1Department of Nuclear Medicine and Endocrine Oncology, Centre de Référence Tumeurs Réfractaires de la Thyroïde, Institut Gustave Roussy and University Paris-Sud XI, 94800 Villejuif, France. schlumbg@igr.fr
European Journal of Endocrinology
|September 6, 2011
Summary
Advanced thyroid cancer patients may benefit from TSH-suppressing thyroxine and local therapies. For radioiodine-refractory cases, kinase inhibitors show promise over chemotherapy.
Area of Science:
- Endocrinology
- Oncology
Background:
- Advanced thyroid cancer presents treatment challenges.
- Radioiodine therapy is a standard treatment but can be ineffective in some patients.
- Cytotoxic chemotherapy has limited efficacy in radioiodine-refractory cases.
Purpose of the Study:
- To review current treatment strategies for advanced thyroid cancer.
- To highlight the role of TSH suppression and local interventions.
- To evaluate emerging therapies like kinase inhibitors.
Main Methods:
- Literature review of treatment modalities for advanced thyroid cancer.
- Analysis of clinical outcomes for various therapeutic approaches.
- Assessment of evidence for kinase inhibitors in refractory disease.
Main Results:
- L-thyroxine therapy with TSH suppression is beneficial.
- Local treatments and radioiodine therapy are important interventions.
- Kinase inhibitors demonstrate encouraging efficacy in radioiodine-refractory patients, outperforming chemotherapy.
Conclusions:
- A multimodal approach including TSH suppression and local therapies is recommended for advanced thyroid cancer.
- Kinase inhibitors represent a promising first-line treatment option for radioiodine-refractory disease.
- Further investigation in prospective trials is warranted for kinase inhibitors.
Related Concept Videos
01:25Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
01:27Nursing Ethical Principles II
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's cancer...
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's cancer...
01:28Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
01:23The Thyroid Gland
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...